Skip to content
★ Sign in to follow
DJ

D Jackson

GlaxoSmithKline plc
Total declarations
106
Company
1
▲ Purchases (4 ops.)
€92k
▼ Sales (4 ops.)
€92k

Latest filing published 08 Jul 2022 for GlaxoSmithKline plc, €2,616.

Filing timeline

BuySale
D Jackson

Insider track record

Disclosed buys
4
Disclosed sells
4
Signal history

Closed purchases

Market purchases
4

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

D Jackson: trading record in brief

This profile gathers the share dealings of D Jackson in GlaxoSmithKline plc. Over a trading history stretching from 9 April 2019 to 6 July 2022, the count stands at 106 filings.

Market trades split into 4 purchases (€92k) and 4 sales (€92k). On balance, insiders were net sellers of €634. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 98 share grants. So far in 2022, the count stands at 2 purchases and 2 sales.

The median purchase comes to €23k.

The record was last updated on 8 July 2022 with a share grant (€2,616) in GlaxoSmithKline plc. The latest purchase dates back some time: it was published 1,614 days ago, on 7 June 2022. Typically, a trade is published a median of 2 days after it takes place. Under the UK Market Abuse Regulation, managers have three business days to notify their trades. Source: insider filings from RNS (LSE). Past trades are no guide to future returns.

Companies and markets linked to D Jackson

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations106 total
  • ◆
    PCA of Ms S Jackson ( SVP, Global Communications and CEO Office)ExecutivesGlaxoSmithKline plc
    2,235 GBP22FCA-NSM
    124.792 shares@ £17.90940.3% of flowLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:4434332-4
  • ◆
    PCA of Ms S Jackson (SVP, Global Communications and CEO Office)ExecutivesGlaxoSmithKline plc
    252 GBP22FCA-NSM
    14 shares@ £17.98930.0% of flowLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:4430446-4
  • ◆
    PCA of Ms S Jackson (SVP, Global Communications and CEO Office)ExecutivesGlaxoSmithKline plc
    141 GBP22FCA-NSM
    8 shares@ £17.65750.0% of flowLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:4428921-1
  • ◆
    PCA of Ms S Jackson (SVP, Global Communications and CEO Office)ExecutivesGlaxoSmithKline plc
    370 GBP22FCA-NSM
    21 shares@ £17.6290.1% of flowLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:4428864-5
  • ◆
    PCA of Ms S Jackson (SVP, Global Communications and CEO Office)ExecutivesGlaxoSmithKline plc
    245 GBP22FCA-NSM
    14 shares@ £17.4750.0% of flowLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:4406847-4
  • ▲
    PCA of Ms S Jackson (SVP, Global Communications and CEO Office)ExecutivesGlaxoSmithKline plc
    19,707 GBP0FCA-NSM
    1,143 shares@ £17.24142.8% of flowLondon Stock Exchange ( XLON)ISIN GB0009252882FCA-NSM:4395886-3
    Canonical exit: 28 Aug 2022 (T+90)
  • ▼
    PCA of Ms S Jackson (SVP, Global Communications and CEO Office)ExecutivesGlaxoSmithKline plc
    19,833 GBP34FCA-NSM
    1,150 shares@ £17.2462.8% of flowLondon Stock Exchange ( XLON)ISIN GB0009252882FCA-NSM:4395886-2
  • ◆
    PCA of Ms S Jackson (SVP, Global Communications and CEO Office)ExecutivesGlaxoSmithKline plc
    243 GBP22FCA-NSM
    14 shares@ £17.34360.0% of flowLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:4370453-4
  • ◆
    PCA of Ms S Jackson ( SVP, Global Communications and CEO Office)ExecutivesGlaxoSmithKline plc
    3,886 GBP22FCA-NSM
    217.786 shares@ £17.84370.6% of flowLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:4339856-5
  • ◆
    PCA of Ms S Jackson (SVP, Global Communications and CEO Office)ExecutivesGlaxoSmithKline plc
    249 GBP22FCA-NSM
    14 shares@ £17.78790.0% of flowLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:4338587-5
  • ◆
    PCA of Ms S Jackson (SVP, Global Communications and CEO Office)ExecutivesGlaxoSmithKline plc
    573 GBP22FCA-NSM
    33 shares@ £17.35550.1% of flowLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:4337075-5
  • ◆
    PCA of Ms S Jackson (SVP, Global Communications and CEO Office)ExecutivesGlaxoSmithKline plc
    69 GBP22FCA-NSM
    4 shares@ £17.3350.0% of flowLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:4336980-1
  • ◆
    PCA of Ms S Jackson (SVP, Global Communications and CEO Office)ExecutivesGlaxoSmithKline plc
    8,995 GBP22FCA-NSM
    744 shares@ £12.091.3% of flowLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:4303984-1
  • ◆
    PCA of Ms S Jackson (SVP, Global Communications and CEO Office)ExecutivesGlaxoSmithKline plc
    245 GBP22FCA-NSM
    16 shares@ £15.32380.0% of flowLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:4300801-5
  • ◆
    PCA of Ms S Jackson (SVP, Global Communications and CEO Office)ExecutivesGlaxoSmithKline plc
    0FCA-NSM
    3,780 sharesN/AISIN GB0009252882FCA-NSM:4277167-11
  • ◆
    PCA of Ms S Jackson (SVP, Global Communications and CEO Office)ExecutivesGlaxoSmithKline plc
    28,124 GBP22FCA-NSM
    1,777 shares@ £15.82694.1% of flowLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:4277167-12
  • ◆
    PCA of Ms S Jackson (SVP, Global Communications and CEO Office)ExecutivesGlaxoSmithKline plc
    0FCA-NSM
    6,330 sharesN/AISIN GB0009252882FCA-NSM:4275792-6
  • ◆
    PCA of Ms S Jackson (SVP, Global Communications and CEO Office)ExecutivesGlaxoSmithKline plc
    0FCA-NSM
    2,976 sharesLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:4275792-7
  • ◆
    PCA of Ms S Jackson (SVP, Global Communications and CEO Office)ExecutivesGlaxoSmithKline plc
    0FCA-NSM
    5,570 sharesN/AISIN GB0009252882FCA-NSM:4275767-6
  • ▼
    PCA of Ms S Jackson (SVP, Global Communications & CEO Office)ExecutivesGlaxoSmithKline plc
    20,019 GBP37FCA-NSM
    1,226 shares@ £16.32872.9% of flowLondon Stock Exchange ( XLON)ISIN GB0009252882FCA-NSM:4271800-2
  • ▲
    PCA of Ms S Jackson (SVP, Global Communications & CEO Office)ExecutivesGlaxoSmithKline plc
    19,886 GBP0FCA-NSM
    1,219 shares@ £16.31332.9% of flowLondon Stock Exchange ( XLON)ISIN GB0009252882FCA-NSM:4271800-3
    Canonical exit: 11 May 2022 (T+90)
  • ◆
    PCA of Ms S Jackson (SVP, Global Communications and CEO Office)ExecutivesGlaxoSmithKline plc
    260 GBP22FCA-NSM
    16 shares@ £16.270.0% of flowLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:4269726-5
  • ◆
    PCA of Ms S Jackson ( SVP, Global Communications and CEO Office)ExecutivesGlaxoSmithKline plc
    2,168 GBP22FCA-NSM
    127.788 shares@ £16.96680.3% of flowLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:4245332-5
  • ◆
    PCA of Ms S Jackson (SVP, Global Communications & CEO Office)ExecutivesGlaxoSmithKline plc
    278 GBP22FCA-NSM
    17 shares@ £16.34470.0% of flowLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:4242449-1
  • ◆
    PCA of Ms S Jackson (SVP, Global Communications and CEO Office)ExecutivesGlaxoSmithKline plc
    458 GBP22FCA-NSM
    28 shares@ £16.35290.1% of flowLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:4240643-5

25 of 106 declarations